These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10997700)

  • 1. Role of vascular endothelial growth factor in diabetic vascular complications.
    Aiello LP; Wong JS
    Kidney Int Suppl; 2000 Sep; 77():S113-9. PubMed ID: 10997700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
    Williams B
    Miner Electrolyte Metab; 1998; 24(6):400-5. PubMed ID: 9930379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
    Duh E; Aiello LP
    Diabetes; 1999 Oct; 48(10):1899-906. PubMed ID: 10512352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose, VEGF-A, and diabetic complications.
    Benjamin LE
    Am J Pathol; 2001 Apr; 158(4):1181-4. PubMed ID: 11290533
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
    Wilkinson-Berka JL; Kelly DJ; Gilbert RE
    J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vascular endothelial growth factor in diabetic nephropathy.
    Cha DR; Kim NH; Yoon JW; Jo SK; Cho WY; Kim HK; Won NH
    Kidney Int Suppl; 2000 Sep; 77():S104-12. PubMed ID: 10997699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).
    Sueishi K; Hata Y; Murata T; Nakagawa K; Ishibashi T; Inomata H
    Pol J Pharmacol; 1996; 48(3):307-16. PubMed ID: 9112668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and its regulation: roles of vascular endothelial cell growth factor.
    Nakagawa K; Chen YX; Ishibashi H; Yonemitsu Y; Murata T; Hata Y; Nakashima Y; Sueishi K
    Semin Thromb Hemost; 2000; 26(1):61-6. PubMed ID: 10805284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.
    Aiello LP; Bursell SE; Clermont A; Duh E; Ishii H; Takagi C; Mori F; Ciulla TA; Ways K; Jirousek M; Smith LE; King GL
    Diabetes; 1997 Sep; 46(9):1473-80. PubMed ID: 9287049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of growth factors in the development of diabetic complications.
    Chiarelli F; Santilli F; Mohn A
    Horm Res; 2000; 53(2):53-67. PubMed ID: 10971090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of cytokines in the pathogenesis of diabetic retinopathy].
    Ohara K; Funatsu H; Kitano S; Hori S; Yamashita H
    Nippon Ganka Gakkai Zasshi; 2001 Apr; 105(4):213-7. PubMed ID: 11329943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P; Tarnow L; Oestergaard PB; Parving HH
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for diabetic complications: Angiogenesis factor].
    Katsura Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():73-8. PubMed ID: 12430210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.